0001035267-23-000105.txt : 20230424
0001035267-23-000105.hdr.sgml : 20230424
20230424200145
ACCESSION NUMBER: 0001035267-23-000105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230421
FILED AS OF DATE: 20230424
DATE AS OF CHANGE: 20230424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUBASH MARK J
CENTRAL INDEX KEY: 0001209186
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30713
FILM NUMBER: 23841330
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTUITIVE SURGICAL INC
CENTRAL INDEX KEY: 0001035267
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 770416458
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
BUSINESS PHONE: 4085232100
MAIL ADDRESS:
STREET 1: 1020 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0407
4
2023-04-21
0
0001035267
INTUITIVE SURGICAL INC
ISRG
0001209186
RUBASH MARK J
1020 KIFER ROAD
SUNNYVALE
CA
94086
1
0
0
0
0
Common Stock
2023-04-21
4
M
0
463
90.4944
A
15463
D
Common Stock
2023-04-21
4
S
0
463
297.8943
D
15000
D
Common Stock
2023-04-21
4
M
0
173
71.3233
A
15173
D
Common Stock
2023-04-21
4
S
0
173
297.8943
D
15000
D
Common Stock
2023-04-21
4
M
0
349
71.3233
A
15349
D
Common Stock
2023-04-21
4
S
0
349
297.9281
D
15000
D
Common Stock
2023-04-21
4
M
0
349
71.3233
A
15349
D
Common Stock
2023-04-21
4
S
0
349
297.9443
D
15000
D
Common Stock
2023-04-21
4
M
0
349
71.3233
A
15349
D
Common Stock
2023-04-21
4
S
0
349
297.9402
D
15000
D
Non-Qualified Stock Option (right to buy)
71.3233
2023-04-21
4
M
0
173
0.0
D
2026-04-21
Common Stock
173
1570
D
Non-Qualified Stock Option (right to buy)
71.3233
2023-04-21
4
M
0
349
0.0
D
2026-04-21
Common Stock
349
1221
D
Non-Qualified Stock Option (right to buy)
71.3233
2023-04-21
4
M
0
349
0.0
D
2026-04-21
Common Stock
349
872
D
Non-Qualified Stock Option (right to buy)
71.3233
2023-04-21
4
M
0
349
0.0
D
2026-04-21
Common Stock
349
523
D
Non-Qualified Stock Option (right to buy)
90.4944
2023-04-21
4
M
0
927
0.0
D
2027-04-20
Common Stock
927
3708
D
Non-Qualified Stock Option (right to buy)
90.4944
2023-04-21
4
M
0
927
0.0
D
2027-04-20
Common Stock
927
2781
D
Non-Qualified Stock Option (right to buy)
90.4944
2023-04-21
4
M
0
927
0.0
D
2027-04-20
Common Stock
927
1854
D
Non-Qualified Stock Option (right to buy)
90.4944
2023-04-21
4
M
0
463
0.0
D
2027-04-20
Common Stock
463
1391
D
Non-Qualified Stock Option (right to buy)
154.2367
2023-04-21
4
M
0
598
0.0
D
2028-04-19
Common Stock
598
2390
D
Non-Qualified Stock Option (right to buy)
154.2367
2023-04-21
4
M
0
598
0.0
D
2028-04-19
Common Stock
598
1792
D
Non-Qualified Stock Option (right to buy)
154.2367
2023-04-21
4
M
0
598
0.0
D
2028-04-19
Common Stock
598
1194
D
Non-Qualified Stock Option (right to buy)
154.2367
2023-04-21
4
M
0
299
0.0
D
2028-04-19
Common Stock
299
895
D
Non-Qualified Stock Option (right to buy)
171.0733
2023-04-21
4
M
0
460
0.0
D
2030-04-23
Common Stock
460
1838
D
Non-Qualified Stock Option (right to buy)
171.0733
2023-04-21
4
M
0
460
0.0
D
2030-04-23
Common Stock
460
1378
D
Non-Qualified Stock Option (right to buy)
171.0733
2023-04-21
4
M
0
460
0.0
D
2030-04-23
Common Stock
460
918
D
Non-Qualified Stock Option (right to buy)
171.0733
2023-04-21
4
M
0
230
0.0
D
2030-04-23
Common Stock
230
688
D
Non-Qualified Stock Option (right to buy)
172.5933
2023-04-21
4
M
0
472
0.0
D
2029-04-25
Common Stock
472
1886
D
Non-Qualified Stock Option (right to buy)
172.5933
2023-04-21
4
M
0
472
0.0
D
2029-04-25
Common Stock
472
1414
D
Non-Qualified Stock Option (right to buy)
172.5933
2023-04-21
4
M
0
472
0.0
D
2029-04-25
Common Stock
472
942
D
Non-Qualified Stock Option (right to buy)
172.5933
2023-04-21
4
M
0
235
0.0
D
2029-04-25
Common Stock
235
707
D
These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 1, 2024.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.45 to $299.15 as follows: 275 shares sold at $296.45 to $297.41; 888 shares sold at $297.48 to $298.48; and 237 shares sold at $298.50 to $299.15. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.62 to $299.27 as follows: 638 shares sold at $296.62 to $297.49; 1,718 shares sold at $297.68 to $298.67; and 450 shares sold at $298.69 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.60 to $299.28 as follows: 638 shares sold at $296.60 to $297.51; 1,768 shares sold at $297.72 to $298.69; and 400 shares sold at $298.74 to $299.28. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.60 to $299.27 as follows: 638 shares sold at $296.60 to $297.49; 1,768 shares sold at $297.73 to $298.69; and 400 shares sold at $298.74 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting
Person's continued service as a director to the issuer.
Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.
By: Donna Spinola For: Rubash, Mark J.
2023-04-24